Related Content
- Mylan ships cholesterol drug
- Dr. Reddy's launches generic asthma, allergy, bronchospasm drug
- Actavis can launch generic OxyContin in January 2014 under settlement with Purdue
- NCPA among industry associations rejecting proposal to reschedule hydrocodone
- Study finds fourfold increase in OxyContin prescriptions dispensed near U.S.-Canada border tunnel
BALTIMORE — Lupin Pharmaceuticals has launched a generic drug for cholesterol disorders, the company said.
Lupin announced the launch of fenofibrate tablets in the 48-mg and 145-mg strengths. The drug is used to treat hypercholesterolemia or mixed dyslipidemia and severe hypertriglyceridemia.
The drug is a generic version of Abbott's Tricor, which had sales of $1.26 billion during the 12-month period ended in June, according to IMS Health.
Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.
